ALMOGRAN Film-coated tablet Ref.[6137] Active ingredients: Almotriptan

Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2015 Publisher: Almirall, S.A., Ronda General Mitre, 151, 08022, Barcelona, Spain

Product name and form

Almogran/Amignul/Almotrex 12.5 mg Film-coated tablet.

Pharmaceutical Form
Film-coated tablet. White, circular, biconvex film-coated tablet with an “A” engraved on one side.

Qualitative and quantitative composition

Each tablet contains almotriptan 12.5 mg as almotriptan D,L-hydrogen malate.

For the full list of excipients, see section 6.1.

Active Ingredient	Description
Almotriptan	Almotriptan is a selective 5-HT_1B and 5-HT_1D receptor agonist. These receptors mediate vasoconstriction of certain cranial vessels, as demonstrated in studies using isolated human tissue preparations.

List of Excipients
Tablet core: Mannitol (E-421) Microcrystalline cellulose Povidone Sodium starch glycolate Sodium stearyl fumarate Coating material: Hypromellose Titanium dioxide (E-171) Macrogol 400 Carnauba wax

Pack sizes and marketing

Boxes containing aluminium foil blisters with 2, 3, 4, 6, 7, 9, 12, 14 or 18 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder

Almirall, S.A., Ronda General Mitre, 151, 08022, Barcelona, Spain

Marketing authorization dates and numbers

PL 16973/0005

Date of last renewal: December 2009

Drugs

Drug	Countries
ALMOGRAN	Germany, Spain, Finland, France, Ireland, Italy, Mexico, Netherlands

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.